Tatiana Moiseeva, PhD, Joins UPMC Hillman Cancer Center

Please join UPMC Hillman Cancer Center in welcoming Tatiana Moiseeva, PhD, effective February 1,  2024. She is an assistant professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and a member of the Genome Stability Program at UPMC Hillman. 

Dr. Moiseeva was a postdoctoral associate at UPMC Hillman with Dr. Chris Bakkenist, where her research focused on the roles of ATM and ATR kinases in regulation of replication proteins and replication origin firing. She is joining us most recently from Tallinn University of Technology in Estonia, where she was senior research scientist, principal investigator, and head of the laboratory of DNA replication and genome stability.  

At UPMC Hillman, Dr. Moiseeva will develop an independently-funded research program in genome stability, which includes collaborative efforts with basic and clinical faculty across the cancer center. She is primarily interested in the investigation of the initiation in DNA replication in human cells.

She has published more than twenty peer-reviewed publications, presented at several national and international scientific conferences, and is the recipient of funding and several awards recognizing her research and teaching excellence. She is an active member of the research enterprise, serving as a reviewer for multiple journals and conferences, mentoring students, and supervising graduate students.

Dr. Moiseeva earned her PhD in molecular biology from the Institute of Cytology of the Russian Academy of Sciences and her Masters of Biophysics and Bachelor or Physics from Saint-Petersburg State Polytechnical University.

Tagged with: